Spyre Therapeutics Inc
(NAS:SYRE)
$
94.12
-8.05 (-7.88%)
Market Cap: 8.17 Bil
Enterprise Value: 7.59 Bil
PE Ratio: 0
PB Ratio: 14.41
GF Score: 26/100 Spyre Therapeutics Inc (SYRE) Transcripts
- 1